Keyphrases
Systemic Sclerosis
100%
Disease Modification
100%
Disease Heterogeneity
22%
Rheumatic Diseases
11%
Chronic Conditions
11%
Fibrosis
11%
Patient Cohort
11%
Therapeutic Potential
11%
Novel Therapeutic Targets
11%
Clinical Evaluation
11%
Autoimmunity
11%
Omics
11%
Clinical Efficacy
11%
Hypothesis Testing
11%
Long-term Morbidity
11%
Disease-modifying Therapy
11%
Clinical Impact
11%
Multiple Organs
11%
Immune Dysregulation
11%
Disease Trajectory
11%
Vascular Damage
11%
Pharmacology, Toxicology and Pharmaceutical Science
Systemic Sclerosis
100%
Diseases
100%
Tamsulosin
11%
Clinical Trial
11%
Rheumatic Disease
11%
Blood Vessel Injury
11%
Side Effect
11%
Fibrosis
11%
Immune Dysregulation
11%
Immunology and Microbiology
Systemic Scleroderma
100%
Autoimmunity
11%
Immune Dysregulation
11%
Rheumatic Disease
11%